Clinical Trial Update: Determining the Safe Dosage of Ascorbic Acid Used in the Treatment of Occluded Totally Implanted Central Venous Catheter [Phase 2]

View source ↗

Summary

Phase 2 trial completed to determine a safe dosage of ascorbic acid for treating an occluded totally implanted central venous catheter.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Occluded Totally Implanted Central Venous Catheter

Drugs mentioned

• Ascorbic acid (Vitamin C)

Snippet

Sponsor: University of Sao Paulo | Conditions: Occluded Totally Implanted Central Venous Catheter | Phase 2 | Status: COMPLETED